Cargando…

Systematic expression analysis of m(6)A RNA methyltransferases in clear cell renal cell carcinoma

OBJECTIVES: To investigate the regulation of the N‐6‐methyladenosine (m(6)A) methyltransferases METTL3, METTL14, WTAP, KIAA1429, and METTL4, referred to as “m(6)A writers,” in clear cell renal cell carcinoma (ccRCC), and other RCC subtypes in respect of the potential prognostic value. PATIENTS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gundert, Larissa, Strick, Alexander, von Hagen, Felix, Schmidt, Doris, Klümper, Niklas, Tolkach, Yuri, Toma, Marieta, Kristiansen, Glen, Ritter, Manuel, Ellinger, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988738/ https://www.ncbi.nlm.nih.gov/pubmed/35474700 http://dx.doi.org/10.1002/bco2.89

Ejemplares similares

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma
por: Brüggemann, Maria, et al.
Publicado: (2017)

LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
por: Ellinger, Jörg, et al.
Publicado: (2016)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
por: Esser, Laura K., et al.
Publicado: (2020)

RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma
por: Simon, Adrian Georg, et al.
Publicado: (2022)

The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma
por: Cox, A., et al.
Publicado: (2020)

Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019)

Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression
por: Bläsius, Felix Marius, et al.
Publicado: (2017)

Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
por: Simon, Adrian Georg, et al.
Publicado: (2020)

Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
por: Heinemann, Frauke G., et al.
Publicado: (2018)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
por: Sanders, Christine, et al.
Publicado: (2022)

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021)

CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2021)

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
por: von Danwitz, Marthe, et al.
Publicado: (2023)

YRNA expression predicts survival in bladder cancer patients
por: Tolkach, Yuri, et al.
Publicado: (2017)

Insights into Urologic Cancer
por: Klümper, Niklas, et al.
Publicado: (2023)

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
por: Condic, Mateja, et al.
Publicado: (2022)

Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels
por: Esser, Laura Kristin, et al.
Publicado: (2022)

Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial
por: Saal, Jonas, et al.
Publicado: (2023)

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
por: Schrödter, Sarah, et al.
Publicado: (2016)

Identification of aberrant tRNA-halves expression patterns in clear cell renal cell carcinoma
por: Nientiedt, Malin, et al.
Publicado: (2016)

Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
por: Condic, Mateja, et al.
Publicado: (2022)

Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
por: Ralser, Damian J., et al.
Publicado: (2022)

Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors
por: Saal, Jonas, et al.
Publicado: (2023)

Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation
por: Nagy, Dora, et al.
Publicado: (2023)

Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers
por: Kremer, Anika, et al.
Publicado: (2019)

The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
por: Syring, Isabella, et al.
Publicado: (2018)

Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
por: Blondeau, Jasmine JC, et al.
Publicado: (2015)

Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
por: Deng, Mario, et al.
Publicado: (2015)

Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma
por: Saal, Jonas, et al.
Publicado: (2023)

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression
por: Klümper, Niklas, et al.
Publicado: (2017)

Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types
por: Syring, Isabella, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v28hdlnv68q05kocah69khds7d